← Back to Bills
S 5428118th CongressFailed / ExpiredSenate

Jeanette Acosta Invest in Women’s Health Act of 2024

Policy Area: Health
View on Congress.gov
Origin Chamber
Senate
Last Updated
Aug 15, 2025
Latest Action Date
Dec 4, 2024

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Jeanette Acosta Invest in Women’s Health Act of 2024 is a Senate bill introduced in the 118th Congress focusing on health policy. The bill was read twice and referred to the Senate Committee on Health, Education, Labor, and Pensions but ultimately failed or expired without further legislative action. No official summary or full text is publicly available, limiting detailed analysis of its provisions or objectives.

Bottom Line

This health-related Senate bill aimed to address women's health issues but did not advance beyond committee referral and expired without enactment.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill was introduced in the Senate during the 118th Congress and referred to the Health, Education, Labor, and Pensions Committee.
  • No official summary or full text is available, so specific policy measures and scope are unknown.
  • The bill status is marked as failed or expired, indicating it did not pass or become law.
Who Benefits?

["Potential beneficiaries would likely include women and health-related agencies or organizations focused on women's health, based on the bill title and policy area."]

Potential Concerns

['Lack of publicly available bill text and summary limits transparency and understanding of implementation requirements or funding mechanisms.', 'Without detailed provisions, it is unclear what oversight or enforcement mechanisms would have been included.', 'The failure to advance suggests possible challenges in legislative support or prioritization.']

Political Context

The bill was introduced in the Senate and referred to the relevant committee but did not progress further. The absence of a summary or text in public records limits insight into its legislative intent or alignment with broader health policy initiatives during the 118th Congress.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

["If enacted, the bill could have influenced funding priorities or program development in women's health, potentially affecting healthcare providers and public health agencies.", "Failure to pass may delay or limit policy advancements in women's health within the legislative session."]

GovScope Watchdog Notes

The absence of an official summary and full text restricts transparency and public oversight. Monitoring legislative progress and ensuring timely publication of bill documents are critical for informed public engagement and accountability. The bill's failure to advance highlights the importance of tracking committee actions and legislative momentum.

Passage Likelihood: LowConfidence: 60%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready